Tags: FDA | approval | bleeding disorder | hemophilia A | Obizur

Drug to Treat Hemophilia

Friday, 24 October 2014 12:48 PM EDT


Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.
The drug, Obizur, has been approved for use in patients with acquired hemophilia A, which usually affects older adults, Baxter said in a statement.
The drug will be launched in the United States in the coming months and is being reviewed by European and Canadian regulators, the company said.

© 2024 Thomson/Reuters. All rights reserved.


Health-Wire
Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.The drug, Obizur, has been approved for use in patients with acquired hemophilia A, which usually...
FDA, approval, bleeding disorder, hemophilia A, Obizur
75
2014-48-24
Friday, 24 October 2014 12:48 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
You May Also Like
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved